In conclusion, our results support the potential role of radiomics and TIME in identifying ALK rearrangements in lung adenocarcinomas and the prognostic value of radiomics in predicting the DFS of patients with ALK rearrangements. The gene discussed is ALK; the disease is lung adenocarcinoma.